SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-047821
Filing Date
2017-12-29
Accepted
2017-12-29 17:03:01
Documents
1
Period of Report
2017-12-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 16462
  Complete submission text file 0001140361-17-047821.txt   17985
Mailing Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063
Business Address 2801 GATEWAY DRIVE SUITE 150 IRVING TX 75063 972-865-2206
REATA PHARMACEUTICALS INC (Issuer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2000 MCKINNEY SUITE 2125 DALLAS TX 75201
Business Address 2000 MCKINNEY SUITE 2125 DALLAS TX 75201 214-871-6816
CPMG Inc (Reporting) CIK: 0001372218 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37785 | Film No.: 171282550